HYPR:NASDAQHyperfine, Inc. Analysis
Data as of 2026-04-09 - not real-time
$1.12
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Hyperfine, Inc. (HYPR) posted a spectacular 128% YoY revenue surge to $13.6M and lifted its gross margin to roughly 50%, signaling strong top‑line momentum and improving product economics. However, the company remains deep in the red with an operating margin of –144% and negative free cash flow, while its stock trades at a lofty price‑to‑sales multiple of 8.1 and a price‑to‑book of 2.65 despite a negative earnings profile.
Technical indicators show the price at $1.12 sitting below the 20‑day (1.158) and 200‑day (1.155) SMAs, an RSI of 48 (neutral), and a bearish MACD histogram, all pointing to short‑term weakness. The stock is also highly volatile (30‑day volatility ≈ 61%) with a computed beta of >2, a recent max drawdown of –59%, and a decreasing volume trend, underscoring elevated market risk.
Technical indicators show the price at $1.12 sitting below the 20‑day (1.158) and 200‑day (1.155) SMAs, an RSI of 48 (neutral), and a bearish MACD histogram, all pointing to short‑term weakness. The stock is also highly volatile (30‑day volatility ≈ 61%) with a computed beta of >2, a recent max drawdown of –59%, and a decreasing volume trend, underscoring elevated market risk.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price below key moving averages
- Bearish MACD and decreasing volume
- High volatility and beta
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Sustained revenue growth and margin expansion
- New product clearances (CE, UKCA, FDA) expanding addressable market
- Strong cash balance relative to minimal debt
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Potential market leadership in portable MRI technology
- Increasing adoption across hospitals and emergency settings
- Long‑run upside from scaling and cost efficiencies
Key Metrics & Analysis
Financial Health
Revenue Growth128.00%
Profit Margin-262.29%
P/E Ratio-3.4
ROE-79.01%
ROA-40.61%
Debt/Equity0.77
P/B Ratio2.7
Op. Cash Flow$-27948000
Free Cash Flow$-17207124
Industry P/E26.4
Technical Analysis
TrendNeutral
RSI48.2
Support$1.03
Resistance$1.39
MA 20$1.16
MA 50$1.14
MA 200$1.16
MACDBearish
VolumeDecreasing
Fear & Greed Index83.57
Valuation
Target Price$2.05
Upside/Downside83.04%
GradeOvervalued
TypeBlend
Risk Assessment
Beta2.17
Volatility61.42%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.